IPX203

Amneal’s long-acting Parkinson’s drug gets cold shoulder from FDA
Medical Marketing and Media
Wed, 07/5/23 - 07:03 pm
Amneal Pharmaceuticals
FDA
Parkinson's Disease
IPX203
FDA accepts Amneal’s NDA for IPX203 to treat Parkinson’s disease
Pharmaceutical Business Review
Mon, 11/14/22 - 10:31 am
Amneal
FDA
IPX203
Parkinson's Disease
Amneal asks FDA to approve another new formulation of Parkinson’s combo drug 
Endpoints
Tue, 09/6/22 - 10:42 am
Amneal
Parkinson's Disease
carbidopa/levodopa
IPX203
Amneal submits NDA to US FDA for Parkinson’s disease treatment
Pharmaceutical Business Review
Thu, 09/1/22 - 10:31 am
Amneal
FDA
Parkinson's Disease
IPX203